Low triiodothyronine syndrome and depression in patients with chronic heart failure

Thyroid and Heart Failure: From Pathophysiology to Clinics

Volumn , Issue , 2009, Pages 203-212

  Bunevičius, Robertas ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

B type natriuretic peptides; Chronic heart failure; Coronary artery disease; Deiodinase; Depression; Hypothalamus pituitary thyroid (HPT) axis; Hypothyroidism; Low T3 syndrome; Pathogenesis; Reverse T3; Treatment resistant depression; Triiodothyronine

Indexed keywords

EID: 80051663512     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-1143-4_18     Document Type: Chapter

References (50)

1. Levy D, Kenchaiah S, Larson M et al (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347:1397-1402
2. Heywood JT, Saltzberg MT (2005) Strategies to reduce length of stay and costs associated with decompensated heart failure. Curr Heart Fail Rep 2:140-147
3. Parish RC, Evans JD (2008) Inflammation in chronic heart failure. Ann Pharmacother 42:1002-1016
4. Portman MA (2008) Thyroid hormone regulation of heart metabolism. Thyroid 18:217-225
5. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007-2018
6. Rutledge T, Reis VA, Linke SE et al (2006) Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48:1527-1537
7. Pingitore A, Landi P, Taddei MC et al (2005) Triiodothy-ronine levels for risk stratification of patients with chronic heart failure. Am J Med 118:132-136
8. Premachandra BN, Kabir MA, Williams IK (2006) Low T3 syndrome in psychiatric depression. J Endocrinol Invest 29:568-572
9. Ustun TB, Ayuso-Mateos JL, Chatterji S et al (2004) Global burden of depressive disorders in the year 2000. Br J Psychiatry 184:386-392
10. Kessler RC, Chiu WT, Demler O et al (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617-627
11. Cook EL, Harman JS (2008) A comparison of health-related quality of life for individuals with mental health disorders and common chronic medical conditions. Public Health Rep 123:45-51
12. Burg MM, Abrams D (2004) Depression in chronic medical illness: the case of coronary heart disease. J Clin Psy-chol 57:1323-1337
13. Malhi GS, Parker GB, Greenwood J (2005) Structural and functional models of depression: from sub-types to substrates. Acta Psychiatr Scand 111:94-105
14. De Groot LJ (2006) Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin 22:57-86
15. Bianco AC, Larsen PR (2005) Intracellular pathways of iodothyronine metabolism. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: a fundamental and clinical text, 9th edn. Lippincott Williams and Wilkins, Philadelphia, pp 109-134
16. Gottlieb SS, Khatta M, Friedmann E et al (2004) The influence of age, gender, and race on the prevalence of depression in heart failure patients. Am Coll Cardiol 43:1542-1549
17. Lett HS, Blumenthal JA, Babyak MA et al (2004) Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 66:305-315
18. van Melle JP, de Jonge P, Spijkerman TA et al (2004) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 66:814-822
19. Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG (2002) Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105:1049-1053
20. Vaccarino V, Kasl SV, Abramson J, Krumholz HM (2001) Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 38:199-205
21. Abramson J, Berger A, Krumholz HM, Vaccarino V (2001) Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 161:1725-1730
22. Murberg TA, Furze G (2004) Depressive symptoms and mortality in patients with congestive heart failure: a six-year follow-up study. Med Sci Monit 10: CR643-648
23. Müller-Tasch T, Peters-Klimm F, Schellberg D et al (2007) Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice. J Card Fail 13:818-824
24. Horwich TB, Hamilton MA, MacLellan WR, Fonarow GC (2002) Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8:216-224
25. Friberg L, Drvota V, Bjelak AH et al (2001) Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med 111:699-703
26. Ascheim DD, Hryniewicz K (2002) Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid 12:511-515
27. Klemperer JD (2002) Thyroid hormone and cardiac surgery. Thyroid 12:517-521
28. Shanoudy H, Soliman A, Moe S et al (2001) Early manifestations of "sick euthyroid" syndrome in patients with compensated chronic heart failure. J Card Fail 7:146-152
29. Schultz M, Faber J, Kistorp C et al (2004) N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clin Endocrinol (Oxf) 60:54-59
30. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ (2004) A systematic review of the diagnostic accuracy of natriuret-ic peptides for heart failure. Arch Intern Med 164:1978-1984
31. Danzi S, Klein I (2004) Thyroid hormone and the cardiovascular system. Minerva Endocrinol 29:139-150
32. Danzi S, Klein I, Portman MA (2005) Effect of triiodothy-ronine on gene transcription during cardiopulmonary bypass in infants with ventricular septal defect. Am J Cardi-ol 95:787-789
33. Morkin E, Pennock GD, Spooner PH et al (2002) Clinical and experimental studies on the use of 3, 5-diiodothyropro-pionic acid, a thyroid hormone analogue, in heart failure. Thyroid 12:527-533
34. Pingitore A, Galli E, Barison A et al (2008) Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 93:1351-1358
35. Van den Berghe G, de Zegher F, Baxter RC et al (1998) Neu-roendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin En-docrinol Metab 83:309-319
36. Baumgartner A (2000) Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. Int J Neuropsychopharmacol 3:149-165
37. Bunevicius R, Lasas L, Kazanavicius G, Prange AJ Jr (1996) Pituitary responses to thyrotropin releasing hormone in depressed women with thyroid gland disorders. Psychoneuroendocrinology 21:631-639
38. Williams M, Harris R, Dayan C et al (2008) Thyroid function and the natural history of depression: findings from the Caerphilly Prospective Study (CaPS) and a meta-analysis. Clin Endocrinol (Oxf) Aug 4 [Epub ahead of print]
39. Kirkegaard C, Faber J (1991) Free thyroxine and 3, 3?, 5?-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinol (Copenh) 124:166-172
40. Lifschytz T, Segman R, Shalom G et al (2006) Basic mechanisms of augmentation of antidepressant effects with thyroid hormone. Curr Drug Targets 7:203-210
41. Nierenberg AA, Fava M, Trivedi MH et al (2006) A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 163:1519-1530
42. Iosifescu DV, Bolo NR, Nierenberg AA et al (2008) Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry 63:1127-1134
43. Bunevicius R, Velickiene D, Prange AJ Jr (2005) Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease. Gen Hosp Psychiatry 27:133-139
44. Saravanan P, Simmons DJ, Greenwood R et al (2005) Partial substitution of thyroxine with tri-iodothyronine in patients on thyroxine replacement therapy: results of a large community-based randomised controlled trial. Clin En-docrinol Metab 90: 805-812
45. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr (1999) Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypohyroidism. N En-gl J Med 340: 424-429
46. Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, Morreale de Escobar G (2005) Treatment of hypothy-roidism with combinations of levothyroxine plus liothyro-nine [review]. J Clin Endocrinol Metab 90:4946-4954
47. Caspi A, Sugden K, Moffitt TE et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389
48. Otte C, McCaffery J, Ali S, Whooley MA (2007) Association of a serotonin transporter polymorphism (5-HTTL-PR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry 164:1379-1384
49. de Jong FJ, Peeters RP, den Heijer T et al (2007) The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 92:636-640
50. Bunevicius R, Varoneckas G, Prange AJ Jr et al (2006) Depression and thyroid axis function in coronary artery disease: impact of cardiac impairment and gender. Clin Car-diol 29:170-174